Guild Esports plc (GILD) ORD GBP0.001
Share news, reports & tips
8 June 2020 14:43
(Sharecast News) - JP Morgan has reiterated its 'overweight' rating on AstraZeneca, following reports that the drugs manufacturer was mulling a possible merger with US rival Gilead Sciences.
8 June 2020 07:33
(Sharecast News) - AstraZeneca has approached Gilead Sciences of the US about a potential merger to create a $240bn drugmaker, according to a report.
7 June 2020 12:21
(Sharecast News) - Fresh evidence of China's shocking cover-up of the pandemic outbreak has been found in censored media reports from Wuhan. Samples taken from sick patients and analysed by at least...
3 February 2020 13:27
(Sharecast News) - Top pharmaceutical companies around the world, including GlaxoSmithKline and Gilead Sciences, are increasingly banding together to try and develop vaccines against the new Chinese...
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.